COVID-19 has presented scientific, clinical and public health challenges. Watch this webinar to learn more about the key data insights that provide government agencies, healthcare providers and life science companies the opportunity to conduct evidence-based analyses in the current COVID-19 landscape and beyond. For example, technology advancements in AI and machine learning helped identify patients earlier, which helped predict COVID-19’s clinical progression and overall impact patient care.
Learn how to:
- Leverage data and interventions to combat a pandemic
- Drive alignment to evidence
- Partner with PINC AI™ Applied Sciences in real-world evidence data generation
Hear from recently appointed Chief Commercial Officer of PINC AI™ Applied Sciences, Myla Maloney, MBA, BCMAS.